These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3511774)

  • 1. Effects of prostaglandins on the pulmonary vascular bed of newborn rats with chronic hypoxia.
    Kashani IA; Richardson B; Lammers RJ; Merritt TA; Bloor CM
    Angiology; 1986 Jan; 37(1):21-6. PubMed ID: 3511774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct pulmonary vascular responses to prostaglandins in the conscious newborn lamb.
    Lock JE; Olley PM; Coceani F
    Am J Physiol; 1980 May; 238(5):H631-8. PubMed ID: 6990790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
    Nakagawa S; Matsui N; Akiba T; Shinoda T; Fukudome Y; Ozawa K; Baba M; Nakanishi T; Takeuchi J
    Proc Eur Dial Transplant Assoc; 1981; 18():117-21. PubMed ID: 7036145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiopulmonary effects of intravenous prostaglandin E1 during experimental one-lung ventilation.
    Bund M; Henzler D; Walz R; Rossaint R; Piepenbrock S
    Thorac Cardiovasc Surg; 2006 Aug; 54(5):341-7. PubMed ID: 16902884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats.
    Deruelle P; Balasubramaniam V; Kunig AM; Seedorf GJ; Markham NE; Abman SH
    Biol Neonate; 2006; 90(2):135-44. PubMed ID: 16582538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease.
    Fitscha P; Kaliman J; Sinzinger H
    Am J Hematol; 1985 May; 19(1):13-9. PubMed ID: 3885723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on the in vivo production of thrombosis in rat mesenteric arterioles and action of prostaglandin (PG) I2 on the thrombosis.
    Takano S; Suzuki T
    Jpn J Pharmacol; 1982 Jun; 32(3):439-44. PubMed ID: 7050479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prostaglandin D2 on perinatal circulation.
    Cassin S; Tod M; Philips J; Frisinger J; Jordan J; Gibbs C
    Am J Physiol; 1981 May; 240(5):H755-60. PubMed ID: 7235033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension.
    Sebkhi A; Strange JW; Phillips SC; Wharton J; Wilkins MR
    Circulation; 2003 Jul; 107(25):3230-5. PubMed ID: 12796132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that hypoxic pulmonary vascular remodeling in rats is polyamine dependent.
    Atkinson JE; Olson JW; Altiere RJ; Gillespie MN
    J Appl Physiol (1985); 1987 Apr; 62(4):1562-8. PubMed ID: 3110122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hypobaric hypoxia in infancy on the subsequent development of vasoconstrictive pulmonary vascular disease in the Wistar albino rat.
    Caslin A; Heath D; Smith P
    J Pathol; 1991 Feb; 163(2):133-41. PubMed ID: 1901909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of indomethacin on fetal rat lungs: a possible cause of persistent fetal circulation (PFC).
    Harker LC; Kirkpatrick SE; Friedman WF; Bloor CM
    Pediatr Res; 1981 Feb; 15(2):147-51. PubMed ID: 7196010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different effects of prostaglandin E1, E2 and D2 on pancreatic somatostatin release.
    Nishi S; Seino Y; Seino S; Tsuda K; Takemura J; Shimizu T; Hayashi O; Imura H
    Horm Metab Res; 1984 Dec; 16 Suppl 1():114-8. PubMed ID: 6152434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic in utero hypoxemia on rat neonatal pulmonary arterial structure.
    Geggel RL; Aronovitz MJ; Reid LM
    J Pediatr; 1986 May; 108(5 Pt 1):756-9. PubMed ID: 3701524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intravitreal and topical prostaglandins on intraocular inflammation.
    Kulkarni PS; Srinivasan BD
    Invest Ophthalmol Vis Sci; 1982 Sep; 23(3):383-92. PubMed ID: 7050005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin releasing polymers - stability and efficacy.
    McRea JC; Ebert CD; Kim SW
    Trans Am Soc Artif Intern Organs; 1981; 27():511-6. PubMed ID: 7036503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of prostaglandins E1 and F2alpha on pulmonary vascular resistance, isolated lobar vessels and cyclic nucleotide levels.
    Kadowitz PJ; Joiner PD; Hyman AL; George WJ
    J Pharmacol Exp Ther; 1975 Mar; 192(3):677-87. PubMed ID: 164534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodilator actions of prostaglandin 6-keto-E1 in the pulmonary vascular bed.
    Hyman AL; Kadowitz PJ
    J Pharmacol Exp Ther; 1980 Jun; 213(3):468-72. PubMed ID: 7193724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary arteries and veins in experimental hypoxia. An ultrastructural study.
    Dingemans KP; Wagenvoort CA
    Am J Pathol; 1978 Nov; 93(2):353-68. PubMed ID: 717535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.